Endocrine-Related Cancer : Impact Factor & More
eISSN: 1479-6821pISSN: 1351-0088
Share this on:
Key Metrics
CiteScore 
9.9
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q1Oncology
SNIP
1.52
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Endocrine-Related Cancer
Endocrine-Related Cancer Journal Specifications
| Overview | |
| Publisher | BIOSCIENTIFICA LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Endocrine-Related Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Endocrine-Related Cancer
Body composition in recurrent prostate cancer and the role of steroidogenic genotype.
- 26 Sep 2026
- Endocrine-related cancer
Prevalence and Clinical Characteristics of Lynch Syndrome-associated Adrenocortical Carcinoma.
- 12 Jan 2026
- Endocrine-related cancer
Cabozantinib for Advanced Grade 3 Neuroendocrine Tumors: Subgroup Analysis of the Phase 3 CABINET Trial (Alliance A021602).
- 12 Jan 2026
- Endocrine-related cancer
Long-term calcitonin after thyroidectomy for Medullary Thyroid Cancer in MEN2A.
- 7 Jan 2026
- Endocrine-related cancer
Elevated Vasoactive Intestinal Peptide Concentrations Poorly Predict VIPoma.
- 7 Jan 2026
- Endocrine-related cancer
Expanding horizons in Endocrine-Related Cancer: innovation, imagination, and a shared global vision
- 1 Jan 2026
- Endocrine-Related Cancer
Body composition in recurrent prostate cancer and the role of steroidogenic genotype.
- 26 Sep 2026
- Endocrine-related cancer
Prevalence and Clinical Characteristics of Lynch Syndrome-associated Adrenocortical Carcinoma.
- 12 Jan 2026
- Endocrine-related cancer
Cabozantinib for Advanced Grade 3 Neuroendocrine Tumors: Subgroup Analysis of the Phase 3 CABINET Trial (Alliance A021602).
- 12 Jan 2026
- Endocrine-related cancer
Long-term calcitonin after thyroidectomy for Medullary Thyroid Cancer in MEN2A.
- 7 Jan 2026
- Endocrine-related cancer
Elevated Vasoactive Intestinal Peptide Concentrations Poorly Predict VIPoma.
- 7 Jan 2026
- Endocrine-related cancer
Expanding horizons in Endocrine-Related Cancer: innovation, imagination, and a shared global vision
- 1 Jan 2026
- Endocrine-Related Cancer
FAQs on Endocrine-Related Cancer
How long has Endocrine-Related Cancer been actively publishing? 
What is the publishing frequency of Endocrine-Related Cancer?
How many articles did Endocrine-Related Cancer publish last year?
What is the eISSN & pISSN for Endocrine-Related Cancer?
What is Citescore for Endocrine-Related Cancer?
What is SNIP score for Endocrine-Related Cancer?
What is the SJR for Endocrine-Related Cancer?
Who is the publisher of Endocrine-Related Cancer?
